Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Head and Neck Neoplasms × Patient Navigation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 13 Breast Neoplasms 10 Lung Neoplasms 9 Uterine Cervical Neoplasms 7 Neoplasms 7 Prostatic Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Patient Compliance 2 Papillomavirus Infections 2 Liver Neoplasms 2 Hematopoietic and Lymphatic System Neoplasm 2 Colorectal Cancer Screening 2 Colonic Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Hepatocellular 2 Tobacco Use 1 Smoking 1 Rectal Neoplasms 1 Psychological Well-Being 1 Overweight 1 Obesity 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma 1 Liver Diseases 1 Hypertension 1 Hepatitis C 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1

Interventions

Cisplatin 208 Radiotherapy 166 Cetuximab 124 pembrolizumab 100 Fluorouracil 79 Docetaxel 76 Paclitaxel 68 Carboplatin 66 Radiotherapy, Intensity-Modulated 62 Surveys and Questionnaires 39 Nivolumab 38 Radiation 31 Drug Therapy 28 Blood Specimen Collection 24 Gemcitabine 22 Immunohistochemistry 20 Gefitinib 20 Erlotinib Hydrochloride 19 durvalumab 18 Surgical Procedures, Operative 18 Standard of Care 17 Magnetic Resonance Spectroscopy 17 Cyclophosphamide 17 Pemetrexed 16 atezolizumab 14 Low-Level Light Therapy 14 Gene Expression Profiling 14 Chemotherapy, Adjuvant 14 Capecitabine 14 Biopsy 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03821064 2021-02-01

NDURE

Medical University of South Carolina

Phase NA Completed

11 enrolled 28 charts

Head and Neck Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡